Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02507466 · ClinicalTrials.gov registry record · NA

Very Intensive Variable Repetitive AmbulatioN Training

A NA study of Stroke, sponsored by Shirley Ryan AbilityLab.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT02507466: Completed NA study of Stroke, sponsored by Shirley Ryan AbilityLab.

NCT02507466 is a NA study of Stroke that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 90 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02507466, a NA study of Stroke, has completed, sponsored by Shirley Ryan AbilityLab.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this subproject is to evaluate the individual and paired contributions of intensity and variability of stepping training on lower extremity (LE) function, health and community participation in patients with chronic hemiparesis post-stroke.

Primary Outcome

fastest comfortable walking speed overground

Conditions Studied

Interventions

  • BEHAVIORAL exercise

Study Locations (1)

Illinois

  • Rehabilitation Institute of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2015-07
Est. Completion 2019-10
Phase NA
Shirley Ryan AbilityLab

138 total trials

What the finished NCT02507466 record still lists

NCT02507466 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which exercise is the first listed.

NCT02507466 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT02507466 about?

NCT02507466 is a clinical study titled "Very Intensive Variable Repetitive AmbulatioN Training". The overall objective of this subproject is to evaluate the individual and paired contributions of intensity and variability of stepping training on lower extremity (LE) function, health and community participation in patients with chronic hemiparesis post-stroke.

What is the current status of trial NCT02507466?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2015-07. Estimated completion is 2019-10.

What conditions does trial NCT02507466 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT02507466?

The interventions under investigation include: exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT02507466?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02507466 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02507466's enrollment target sits among peer trials

90 154th of 454 higher than 297 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02507466, the US trial registry maintained by the National Library of Medicine. NCT02507466 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.